Skip to main content

Myomo, Inc.

MYO
Exchange
NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001369290

In the last 90 days, Myomo, Inc. insiders filed 0 open-market purchases and 3 sales; 79 institutions reported holding it in 13F filings for Q2 2026, worth $12.7M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Myomo, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
2 insiders, $71.2K in total
Insiders trading
2
Net value
−$71.2K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Myomo, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Myomo, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Kovelman HarryChief Medical Officer90,245Sep 14, 20266
Morris Milton MayoDirector208,391Sep 4, 20262
Mitchell MicahChief Commercial Officer130,738Aug 11, 20264
Gudonis Paul RChief Executive Officer1,434,679Aug 11, 20264
Henry David AChief Financial Officer470,163Aug 11, 20266
Kirk Thomas FDirector772,569Jun 26, 20266
Febbo William JDirector123,704Jun 26, 20262
Getz Heather CDirector210,458Jun 26, 20263
Manko Joseph M. Jr.Director78,704Jun 26, 20262
Crowley Thomas Aloysius Jr.Director154,452Jun 26, 20262
Knapp Amy K.Director91,645Jun 7, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2026 (view filing)4:30 PM ETSep 113 daysKovelman HarryChief Medical OfficerSSale−15.5K$1.27−$19.7K−14.6%90.2K after
Sep 4, 2026 (view filing)4:30 PM ETSep 22 daysMorris Milton MayoDirectorSSale−15.0K$1.41−$21.1K−6.7%208.4K after
Aug 24, 2026 (view filing)8:08 AM ETAug 204 daysKovelman HarryChief Medical OfficerSSale−17.5K$1.73−$30.3K−14.2%105.7K afterAmended
Jun 9, 2026 (view filing)Jun 54 daysKirk Thomas FDirectorPPurchase+40.0K$1.27+$50.8K+6.1%693.9K after
Jun 8, 2026 (view filing)May 1425 daysMitchell MicahChief Commercial OfficerSSale−90.2K$0.86−$77.6K−45.2%109.5K afterAmended
Jun 1, 2026 (view filing)May 284 daysKirk Thomas FDirectorPPurchase+25.0K$0.99+$24.8K+4.0%653.9K after
May 28, 2026 (view filing)May 27-281 dayKovelman HarryChief Medical OfficerSSale−32.0K$1.01−$32.2K−22.8%108.6K after2 lots
May 18, 2026 (view filing)May 14-154 daysManko Joseph M. Jr.DirectorPPurchaseMYO+201.2K$0.8645+$173.9K+9.5%2.31M after2 lots
May 18, 2026 (view filing)May 15-183 daysKirk Thomas FDirectorPPurchase+75.0K$0.91+$68.3K+13.5%628.9K after2 lots
Mar 17, 2026 (view filing)Mar 161 dayGetz Heather CDirectorPPurchase+20.0K$0.70+$14.0K+17.9%131.8K after
Mar 16, 2026 (view filing)Mar 133 daysKirk Thomas FDirectorPPurchase+72.0K$0.71+$51.1K+14.9%553.9K after
Mar 12, 2026 (view filing)Mar 12Same dayGetz Heather CDirectorPPurchase+70.0K$0.73+$51.1K+167.6%111.8K after
Nov 24, 2025 (view filing)Nov 20-214 daysKirk Thomas FDirectorPPurchase+7.44K$0.72+$5.35K+1.6%481.9K after2 lots
Nov 21, 2025 (view filing)Nov 183 daysLateCrowley Thomas Aloysius Jr.DirectorPPurchase+4.00K$0.73+$2.92K+5.6%75.7K after
Nov 21, 2025 (view filing)Nov 192 daysCrowley Thomas Aloysius Jr.DirectorPPurchase+385$0.77+$296.45+409.6%479 after
Aug 26, 2025 (view filing)Aug 251 dayKirk Thomas FDirectorPPurchase+50.0K$1.15+$57.5K+11.8%474.4K after
Aug 19, 2025 (view filing)Aug 181 dayKirk Thomas FDirectorPPurchase+50.0K$1.10+$55.0K+13.4%424.4K after
Aug 18, 2025 (view filing)Aug 153 daysGudonis Paul RChief Executive OfficerPPurchase+50.0K$0.95+$47.5K+4.1%1.26M after
May 15, 2025 (view filing)May 14-151 dayKirk Thomas FDirectorPPurchase+38.8K$3.25+$126.0K+12.7%344.7K after2 lots
May 15, 2025 (view filing)May 15Same dayGudonis Paul RChief Executive OfficerPPurchase+30.0K$3.22+$96.6K+2.9%1.05M after
May 14, 2025 (view filing)May 122 daysKirk Thomas FDirectorPPurchase+50.0K$3.35+$167.5K+19.5%305.9K after
Mar 21, 2025 (view filing)Mar 147 daysMitchell MicahChief Commercial OfficerSSale−48.0K$5.16−$247.7K−25.5%140.3K afterAmended
Mar 14, 2025 (view filing)Mar 131 dayKirk Thomas FDirectorPPurchase+7.40K$5.00+$37.0K+3.0%255.9K after
Mar 14, 2025 (view filing)Mar 14Same dayMitchell MicahChief Commercial OfficerSSale−48.0K$5.16−$247.7K−25.5%140.6K after
Mar 13, 2025 (view filing)Mar 121 dayKovelman HarryChief Medical OfficerSSale−30.0K$5.50−$165.0K−23.4%98.0K after
Sep 9, 2024 (view filing)Sep 54 daysKovelman HarryChief Medical OfficerSSale−6.70K$3.76−$25.2K−5.1%123.6K after
Sep 5, 2024 (view filing)Sep 32 daysKovelman HarryChief Medical OfficerSSale−2.03K$4.01−$8.14K−1.5%130.4K after
May 31, 2024 (view filing)May 292 daysKirk Thomas FDirectorPPurchase+50.0K$3.50+$175.0K+26.8%236.5K after
May 17, 2024 (view filing)May 152 daysKovelman HarryChief Medical OfficerSSale−35.4K$3.69−$130.7K−26.5%98.0K after
Mar 18, 2024 (view filing)Mar 144 daysKirk Thomas FDirectorPPurchase+50.0K$3.50+$175.0K+36.6%186.5K after
Dec 14, 2023 (view filing)Nov 2024 daysLateKirk Thomas FDirectorPPurchase+50.0K$3.10+$155.0K+57.8%136.5K after
Dec 8, 2023 (view filing)Dec 8Same dayCrowley Thomas Aloysius Jr.DirectorSSale−15.0K––−33.3%30.0K after
Dec 5, 2023 (view filing)Dec 14 daysKovelman HarryChief Medical OfficerSSale−8.33K––−5.6%140.9K after10b5-1
Nov 30, 2023 (view filing)Nov 282 daysCrowley Thomas Aloysius Jr.DirectorSSale−15.0K––−25.0%45.0K after
Sep 11, 2023 (view filing)Sep 83 daysMorris Milton MayoDirectorPPurchase+15.0K$1.06+$15.9K+23.8%77.9K after
Aug 31, 2023 (view filing)Aug 301 dayGudonis Paul RChief Executive OfficerPPurchase+48.4K$0.74+$35.8K+5.8%878.2K after
Aug 30, 2023 (view filing)Aug 28-292 daysGudonis Paul RChief Executive OfficerPPurchase+79.5K$0.764+$60.7K+10.6%829.8K after2 lots
Jun 30, 2023 (view filing)Jun 6-14, 2022389 daysLateCrowley Thomas Aloysius Jr.DirectorSSale−12.9K$2.09−$27.0K−100.0%0 after5 lots
Jan 18, 2023 (view filing)7:07 PM ETJan 171 dayMitchell MicahChief Commerical OfficerPPurchase+15.4K$0.325+$5.00K+31.1%64.8K after
Jan 18, 2023 (view filing)7:02 PM ETJan 171 dayHenry David AChief Financial OfficerPPurchase+76.9K$0.325+$25.0K+88.8%163.5K after
Jan 18, 2023 (view filing)6:59 PM ETJan 171 dayGudonis Paul RChief Executive OfficerPPurchase+307.7K$0.325+$100.0K+175.2%483.3K after
Nov 22, 2022 (view filing)Nov 22Same dayHenry David AChief Financial OfficerPPurchase+9.00K$0.55+$4.95K+11.6%86.6K after
Aug 8, 2022 (view filing)Aug 53 daysCrowley Thomas Aloysius Jr.DirectorSSale−7.14K$1.71−$12.2K−35.6%12.9K after
Mar 16, 2022 (view filing)Mar 142 daysGudonis Paul RChief Executive OfficerPPurchase+5.00K$4.22+$21.1K+5.7%92.0K after
Mar 11, 2022 (view filing)Mar 11Same dayGudonis Paul RChief Executive OfficerPPurchase+5.00K$4.63+$23.1K+6.1%87.0K after
Nov 16, 2021 (view filing)Nov 16Same dayHenry David AChief Financial OfficerPPurchase+1.00K$8.86+$8.86K+2.9%35.6K after
Nov 16, 2021 (view filing)Nov 124 daysGudonis Paul RChief Executive OfficerPPurchase+1.00K$9.86+$9.86K+1.2%82.0K after
Jul 22, 2021 (view filing)Jul 20-212 daysMitchell MicahChief Commerical OfficerSSale−7.13K––−31.0%15.9K after2 lots